Antivenom is the mainstay of treatment of snakebite envenoming. However, adverse
reactions to snake antivenom that is available are common in many parts of the world where …

Snakebite envenoming is a neglected public health challenge of compelling importance in
many regions of the world, particularly sub-Saharan Africa, Asia, Latin America and Papua …

Venomous snakebite is considered the single most important cause of human injury from
venomous animals worldwide. Coagulopathy is one of the commonest important systemic …

The clinical and epidemiological features, as well as complications presented by 39 patients
with Bothrops, Porthidium and Bothriechis snakebites, are described. Patients were admitted …

Thirty-one of 75 extracts of plants used by traditional healers for snakebites, had moderate
or high neutralizing ability against the haemorrhagic effect of Bothrops atrox venom from …

The mainstay of hospital treatment for venomous snakebite is antivenom. There is currently
only one antivenom available in the United States for the treatment of pit viper …

Parenteral administration of horse-and sheep-derived antivenoms constitutes the
cornerstone in the therapy of envenomations induced by animal bites and stings. Depending …

Bothrops asper inflicts the majority of snakebites in Central America and in the northern
regions of South America, mostly affecting young agricultural workers in rural settings. This …

Hematologic abnormalities are the most common effects of snake envenoming globally.
Venom-induced consumption coagulopathy (VICC) is the commonest and most important …

Snake antivenoms are formulations of immunoglobulins, or immunoglobulin fragments,
purified from the plasma of animals immunized with snake venoms. Their therapeutic …